Investigational Drug Information for troriluzole
✉ Email this page to a colleague
What is the development status for investigational drug troriluzole?
troriluzole is an investigational drug.
There have been 8 clinical trials for troriluzole.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 19th 2019.
The most common disease conditions in clinical trials are Disease, Obsessive-Compulsive Disorder, and Compulsive Personality Disorder. The leading clinical trial sponsors are Biohaven Pharmaceuticals, Inc., Cognitive Research Corporation, and Cytel Inc.
There are two US patents protecting this investigational drug and thirty-three international patents.
Summary for troriluzole
| US Patents | 2 |
| International Patents | 33 |
| US Patent Applications | 34 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2019-02-19) |
| Vendors | 15 |
Recent Clinical Trials for troriluzole
| Title | Sponsor | Phase |
|---|---|---|
| Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets | Biohaven Pharmaceuticals, Inc. | Phase 2 |
| Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets | Dana-Farber Cancer Institute | Phase 2 |
| Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder | Biohaven Pharmaceuticals, Inc. | Phase 3 |
Clinical Trial Summary for troriluzole
Top disease conditions for troriluzole
Top clinical trial sponsors for troriluzole
US Patents for troriluzole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| troriluzole | ⤷ Try a Trial | Riluzole prodrugs and their use | Biohaven Therapeutics Ltd. (New Haven, CT) | ⤷ Try a Trial |
| troriluzole | ⤷ Try a Trial | Prodrugs of riluzole and their method of use | Biohaven Therapeutics Ltd. (New Haven, CT) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for troriluzole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| troriluzole | Australia | AU2016226463 | 2035-03-03 | ⤷ Try a Trial |
| troriluzole | Australia | AU2020233650 | 2035-03-03 | ⤷ Try a Trial |
| troriluzole | Australia | AU2022202163 | 2035-03-03 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
